Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Pelthos Therapeutics Inc. (PTHS) had Pre-Tax Income of $-7.89M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$15.39M |
|
$-7.89M |
|
$1.66M |
|
$13.73M |
|
$25.09M |
|
$-9.69M |
|
$1.80M |
|
|
Pre-Tax Income |
$-7.89M |
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-9.69M |
|
$-8.04M |
|
3.86M |
|
3.86M |
|
$-2.04 |
|
$-2.04 |
|
| Balance Sheet Financials | |
$56.07M |
|
$8.51M |
|
$72.75M |
|
$128.82M |
|
$31.43M |
|
$65.25M |
|
$103.57M |
|
$135.00M |
|
$-6.19M |
|
$-67.21M |
|
$-6.19M |
|
3.90M |
|
| Cash Flow Statement Financials | |
$-25.95M |
|
$-0.26M |
|
$26.35M |
|
$18.02M |
|
$18.16M |
|
$0.14M |
|
$6.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
1.10 |
|
-10.55 |
|
89.21% |
|
-62.96% |
|
-62.96% |
|
-- |
|
-51.28% |
|
-51.28% |
|
$-26.21M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.08 |
|
1.15 |
|
78.41 |
|
127.63% |
|
11.75% |
|
-6.13% |
|
-13.37% |
|
$-1.59 |
|
$-6.78 |
|
$-6.72 |
|